AMCAL is offering its customers a health assessment with a focus on diabetes with its “personalised Diabetes Management Review” following the release of a new diabetes report from the company.
THE Federal Court of Australia has ruled against a WA pharmacist who claimed he was defamed by conditions being imposed on his registration and subsequent publication by the Pharmacy Board of Australia & the Australian Health Practitioner Regulatory Agency.
AUSTRALIAN Pharmaceutical Industries has refined tactical sales activity and continues to develop exclusive products and range extensions, as part of a strategy to combat weak consumer demand which saw the company report a 24.9% decline in H1 net profit to $24.9 million (PD breaking news).
